Good afternoon :)
$
₹
ResMed Inc

ResMed Inc

RMD

NYSE
Asset Logo

ResMed Inc

RMD

NYSE
$225.241.39% (-3.17)
$
₹
$225.241.39% (-3.17)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Large Cap

With a market cap of $32.5B the stock is ranked 447

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

21.55
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

4.92
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$10.44
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.30
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

26.95%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

1.05%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 19 analysts' reports

Buy
12 analysts
Hold
6 analysts
Sell
1 analyst

Analysts expect a +10.03% price upside over the next year

Current Price$225.24
Target Price$247.56

Company Profile

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
33.20
33.20
1Y Return
23.69%
23.69%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
37.75
37.75
1Y Return
9.01%
9.01%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
45.05
45.05
1Y Return
11.99%
11.99%
Buy Reco %
66.66
66.66
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.69
22.69
1Y Return
2.88%
2.88%
Buy Reco %
53.12
53.12
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
28.48
28.48
1Y Return
27.02%
27.02%
Buy Reco %
68.75
68.75

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
ResMed Inc 21.554.921.30
Abbott Laboratories33.203.471.88
Danaher Corporation37.752.831.26

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

1.3
0.3
1.4
0.3
1.4
0.3
1.4
0.3
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue1.191.221.221.281.291.341.331.421.431.46
Net Income0.300.290.310.340.360.370.340.390.390.38
Net Profit Margin25.10%23.89%25.42%26.87%28.25%28.16%26.09%27.59%27.85%26.19%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. ResMed Inc (RMD) share price today is $225.24 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $228.38 and a day low of $225.09.

  2. ResMed Inc stock trades on NYSE under the ticker symbol RMD.

  3. ResMed Inc's market capitalization is $32.45B as of September 19, 2026 at 1:30 AM IST.

  4. ResMed Inc's price-to-earnings (P/E) ratio is 21.55 as of September 21, 2026.

  5. ResMed Inc's price-to-book (P/B) ratio is 4.92 as of September 21, 2026.

  6. Yes, ResMed Inc pays a dividend, with a current dividend yield of 1.05%.

  7. Yes, You can buy ResMed Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy ResMed Inc shares in three steps: 1. Search ResMed Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since ResMed Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in ResMed Inc (RMD) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0443 shares at the current price of $225.24.

Loading...